Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” [Bioorg. Med. Chem. Lett. 29(8) (2019) 995–1000]

Benzer Materyaller

• Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury
  Yazar:: Goncalves, Maria B., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review
  Yazar:: Borthwick, Alan D., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Neuronal RARβ Signaling Modulates PTEN Activity Directly in Neurons and via Exosome Transfer in Astrocytes to Prevent Glial Scar Formation and Induce Spinal Cord Regeneration
  Yazar:: Goncalves, Maria B., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Corrigendum to “Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA(A) receptor ligands” [Bioorg. Med. Chem. Lett. 25/2 (2015) 400–403]
  Yazar:: Rycek, Lukas, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• RARβ Agonist Drug (C286) Demonstrates Efficacy in a Pre-clinical Neuropathic Pain Model Restoring Multiple Pathways via DNA Repair Mechanisms
  Yazar:: Goncalves, Maria B., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)